“…Dual-mode probes combining light-emitting QDs or Ln-UCNPs with MRI contrast agents have been developed using multiple approaches, including core-shell nanostructures [127], chelate conjugation [128,129], and Gd 3+ or Mn 2+ co-doping [130,131]. Hu et al developed a dual-modality nanoprobe based on Ag 2 S QDs, which emits in the second biological window and conjugated with the Gd-DOTA MRI contrast agent [132].…”